Alnylam Pharmaceuticals, Inc. Share Price
Equities
ALNY
US02043Q1076
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
148.6 USD | -0.99% | -1.30% | -22.19% |
Sales 2024 * | 1.87B 147B | Sales 2025 * | 2.26B 178B | Capitalization | 18.98B 1,493B |
---|---|---|---|---|---|
Net income 2024 * | -451M -35.47B | Net income 2025 * | -257M -20.21B | EV / Sales 2024 * | 9.47 x |
Net cash position 2024 * | 1.26B 99.29B | Net cash position 2025 * | 475M 37.34B | EV / Sales 2025 * | 8.19 x |
P/E ratio 2024 * |
-42.5
x | P/E ratio 2025 * |
-80.6
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.59% |
Latest transcript on Alnylam Pharmaceuticals, Inc.
1 day | -1.05% | ||
1 week | -1.30% | ||
Current month | +3.46% | ||
1 month | +1.07% | ||
3 months | -1.43% | ||
6 months | -9.19% | ||
Current year | -22.19% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 18/09/16 | |
Jeffrey Poulton
DFI | Director of Finance/CFO | 56 | 12/08/19 |
Piyush Sharma
CMP | Compliance Officer | - | 20/09/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 17/12/15 |
Charles Sigal
BRD | Director/Board Member | 72 | 21/08/22 |
Margaret Hamburg
BRD | Director/Board Member | 68 | 09/01/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.08% | 1 M€ | 0.00% | - | |
4.04% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
29/05/24 | 149 | -0.69% | 145 450 |
28/05/24 | 150.1 | +1.56% | 510,344 |
24/05/24 | 147.8 | -1.08% | 506,806 |
23/05/24 | 149.4 | -1.01% | 500,527 |
22/05/24 | 150.9 | +0.86% | 350,723 |
Delayed Quote Nasdaq, May 29, 2024 at 05:52 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.19% | 18.98B | |
+46.39% | 58.71B | |
-3.31% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.64% | 26.55B | |
+1.27% | 12.51B | |
+25.97% | 12.08B | |
+21.08% | 11.94B | |
-10.90% | 11.05B |
- Stock Market
- Equities
- ALNY Stock